Colgate-Palmolive (NYSE:CL) Shares Purchased by Great Valley Advisor Group Inc.

Great Valley Advisor Group Inc. grew its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 76.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,387 shares of the company's stock after acquiring an additional 6,224 shares during the period. Great Valley Advisor Group Inc.'s holdings in Colgate-Palmolive were worth $1,494,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Meridian Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $1,133,000. AlphaCore Capital LLC lifted its position in shares of Colgate-Palmolive by 21.9% during the 3rd quarter. AlphaCore Capital LLC now owns 4,454 shares of the company's stock valued at $462,000 after acquiring an additional 800 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of Colgate-Palmolive by 0.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,595,245 shares of the company's stock valued at $477,032,000 after acquiring an additional 11,750 shares during the period. Banco Santander S.A. lifted its position in shares of Colgate-Palmolive by 663.5% during the 3rd quarter. Banco Santander S.A. now owns 148,702 shares of the company's stock valued at $15,437,000 after acquiring an additional 129,225 shares during the period. Finally, L & S Advisors Inc acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $4,295,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.3 %

Shares of NYSE CL traded up $1.25 during trading on Tuesday, hitting $96.59. 4,380,654 shares of the company traded hands, compared to its average volume of 4,390,990. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a 50-day moving average price of $97.74 and a 200-day moving average price of $98.59. The firm has a market capitalization of $78.91 billion, a P/E ratio of 27.68, a P/E/G ratio of 3.39 and a beta of 0.42. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. Colgate-Palmolive's dividend payout ratio is presently 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.37% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CL has been the subject of a number of research reports. Piper Sandler began coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target for the company. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price objective for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Sanford C. Bernstein lifted their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a "market perform" rating in a research report on Tuesday, July 30th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, October 28th. Finally, Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an "equal weight" rating in a research report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.